Are you measuring what matters most for your brand? Many key performance indicators (KPIs) are used to measure the success of adherence programs, and they can vary across different pharmaceutical companies and settings. For example,…
Read more
Medication non-adherence continues to be one of the most widespread issues faced by the pharmaceutical industry. According to the U.S. Centers for Disease Control, approximately 50 percent of people with chronic illnesses stop taking their…
Read more
Pharmaceutical companies have aspired to make medication adherence programs more effective for years. A report from Credit Suisse shows that increased adherence could substantially increase revenue from 2020–2026 for leading pharma companies such as Merck,…
Read more
We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise…
Read more
Eli Lilly and Co. and Abbott have made headlines recently for using real-world evidence to prove better adherence and outcomes for its diabetes products. More pharma companies are likely to utilize real-world data to support…
Read more
With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers. According to Andrea Kasprzyk, Director of Sales at…
Read more
A leading pharmaceutical company engaged AllazoHealth on a multi-year project using artificial intelligence to optimize a patient support program for a major product. Overcoming an adherence challenge The pharmaceutical company faced a challenge: An estimated…
Read more